These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16730752)

  • 1. Glipizide matrix transdermal systems for diabetes mellitus: preparation, in vitro and preclinical studies.
    Mutalik S; Udupa N; Kumar S; Agarwal S; Subramanian G; Ranjith AK
    Life Sci; 2006 Sep; 79(16):1568-77. PubMed ID: 16730752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations.
    Mutalik S; Udupa N
    J Pharm Sci; 2004 Jun; 93(6):1577-94. PubMed ID: 15124215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of membrane-moderated transdermal system of glipizide.
    Mutalik S; Udupa N
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):17-26. PubMed ID: 16445694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, in vitro and in vivo evaluation of glipizide Eudragit microparticles.
    Madhusudhan S; Panda AK; Parimalakrishnan S; Manavalan R; Manna PK
    J Microencapsul; 2010; 27(4):281-91. PubMed ID: 20515261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transdermal delivery system for glipizide.
    Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
    Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
    Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
    Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
    Mutalik S; Udupa N
    Pharmazie; 2002 Dec; 57(12):838-41. PubMed ID: 12561248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.
    Mukherjee B; Mahapatra S; Gupta R; Patra B; Tiwari A; Arora P
    Eur J Pharm Biopharm; 2005 Apr; 59(3):475-83. PubMed ID: 15760728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive and iontophoretic permeation of glipizide gel: an in vitro and in vivo study.
    Ghosh B; Jain A; Ashok P; Patel B; Tarafdar K
    Curr Drug Deliv; 2009 Oct; 6(5):444-50. PubMed ID: 19751199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
    Kushare SS; Gattani SG
    J Pharm Pharmacol; 2013 Jan; 65(1):79-93. PubMed ID: 23215691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
    Arora P; Mukherjee B
    J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
    Baviskar DT; Parik VB; Jain DJ
    PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of matrix diffusion controlled transdermal patches of coumarin.
    Prabu SL; Thiyagarajan S; Suriyaprakash TN
    Curr Drug Deliv; 2013 Apr; 10(2):167-73. PubMed ID: 22998642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Evaluation of Transdermal Patches of Timolol Maleate.
    Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
    Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of nefopam transdermal matrix patch system in human volunteers.
    De P; Damodharan N; Mallick S; Mukherjee B
    PDA J Pharm Sci Technol; 2009; 63(6):537-46. PubMed ID: 20169860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
    Ahad HA; Ishaq BM; Shaik M; Bandagisa F
    Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit-based transdermal delivery system of pentazocine: Physico-chemical, in vitro and in vivo evaluations.
    Chandak AR; Prasad Verma PR
    Pharm Dev Technol; 2010 Jun; 15(3):296-304. PubMed ID: 22716470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive and iontophoretic permeation of glipizide.
    Jain A; Ghosh B; Rajgor N; Desai BG
    Eur J Pharm Biopharm; 2008 Aug; 69(3):958-63. PubMed ID: 18291633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.